Aldose Reductase Inhibitors and Nanodelivery of Diabetic Therapeutics

Author(s): A. M. Prior, M. Thapa, D. H. Hua

Journal Name: Mini-Reviews in Medicinal Chemistry

Volume 12 , Issue 4 , 2012

Become EABM
Become Reviewer
Call for Editor


Nanotechnology is a rapidly emerging drug-delivery system that makes possible the controlled release of small molecules, and nanodelivery of therapeutic molecules using nanoparticles or nanogels represents a major improvement for more focused delivery of such therapeutic molecules. The delivery of insulin for the control of diabetes mellitus (DM) and aldose reductase inhibitor (ARI) for diabetic complications may provide better treatment of diabetes. A structural overview of aldose reductase including computational docking experiments with HAR-1, various ARIs, aldose-keto reductase, and nanodelivery of insulin, ARI's, and drug molecules are described.

Keywords: Aldose reductase, aldose reductase inhibitors, aldo-keto reductase, diabetes, insulin, nanodelivery, nanogels, tricyclic pyrone molecules, sorbitol, dehydrogenase, nicotinamide adenine dinucleotide, nicotinamide adenine dinucleotide phosphate, glutathione reductase, glycation, nasal, rectal, pulmonary, microparticles, pre-clinical

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2012
Published on: 25 April, 2012
Page: [326 - 336]
Pages: 11
DOI: 10.2174/138955712799829294
Price: $65

Article Metrics

PDF: 14